Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Maspin sensitizes breast carcinoma cells to induced apoptosis

Abstract

Maspin, a novel serine protease inhibitor (serpin), suppresses the growth and metastasis of breast tumor in vivo. However, the underlying molecular mechanism is unclear. In the current study, we report the first evidence that endogenous maspin expression in mammary carcinoma cells MDA-MB-435 enhanced staurosporine (STS)-induced apoptosis as judged by the increased fragmentation of DNA, increased proteolytic inactivation of poly-[ADP-ribose]-polymerase (PARP), as well as the increased activation of caspase-8 and caspase-3. In parallel, recombinant maspin did not directly regulate the proteolytic activities of either caspase-3 or caspase-8 in vitro. Consistent with this result, maspin expressing normal mammary epithelial cells underwent more rapid STS-induced apoptosis as compared to breast carcinoma cells. Interestingly, maspin transfectant cells did not undergo spontaneous apoptosis in the absence of STS. Moreover, neither purified maspin protein added from outside nor endogenous maspin secreted to the cell culture media sensitized cells to STS-induced apoptosis. To investigate the structural determinants of maspin in its apoptosis-sensitizing effect, MDA-MB-435 cells were also transfected with maspin/PAI-1 and PAI-1/maspin chimeric constructs resulting from swapping the N-terminal and the C-terminal domains between maspin and PAI-1 (plasminogen activator inhibitor type 1). The resulting stable transfectant clones expressing maspin/PAI-1 and PAI-1/maspin, respectively, did not undergo spontaneous apoptosis, and were similarly inhibited as maspin transfectant cells in motility assay. Interestingly, however, expression of both maspin/PAI-1 and PAI-1/maspin in MDA-MB-435 cells failed to sensitize these cells to STS-induced apoptosis. Taken together, our evidence provides new insights into the complex molecular mechanisms of maspin that may suppress breast tumor progression not only at the step of invasion and motility, but also by regulating tumor cell apoptosis. The sensitizing effect of maspin on apoptosis is to be contrasted by the pro-survival effect of several other serpins.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Andreasen PA, Egelund R, Petersen HH . 2000 Cell Mol. Life Sci. 57: 25–40

  • Band V, Sager R . 1989 Proc. Natl. Acad. Sci. USA 86: 1249–1253

  • Biliran Jr H, Sheng S . 2001 Cancer Res. 61: 8676–8682

  • Biswas DK, Dai S, Cruz A, Weiser B, Graner E, Pardee AB . 2001 Proc. Natl. Acad. Sci. USA 98: 10386–10391

  • Blasi F . 1999 Thromb. Haemost. 82: 298–304

  • Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M . 1999 J. Biol. Chem. 274: 22932–22940

  • Bromme HJ, Holtz J . 1996 Mol Cell Biochem 163–164: 261–275

  • Budihardjo I, Oliver H, Lutter M, Luo X, Wang X . 1999 Annu. Rev. Cell Dev. Biol. 15: 269–290

  • Chen CY, Juo P, Liou JS, Li CQ, Yu Q, Blenis J, Faller DV . 2001 Cell Growth Differ. 12: 297–306

  • D'Amours D, Germain M, Orth K, Dixit VM, Poirier GG . 1998 Radiat. Res. 150: 3–10

  • Dickinson JL, Bates EJ, Ferrante A, Antalis TM . 1995 J. Biol. Chem. 270: 27894–27904

  • Dickinson JL, Norris BJ, Jensen PH, Antalis TM . 1998 Cell Death Differ. 5: 163–171

  • Gomez-Angelats M, Bortner CD, Cidlowski JA . 2000 J. Biol. Chem. 275: 19609–19619

  • Hall AK . 1995 Cell Mol. Biol. Res. 41: 167–180

  • Hopkins PC, Whisstock J . 1994 Science 265: 1893–1894

  • Jacobsen MD, Weil M, Raff MC . 1996 J. Cell Biol. 133: 1041–1051

  • Kanamori H, Krieg S, Mao C, Di Pippo VA, Wang S, Zajchowski DA, Shapiro DJ . 2000 J. Biol. Chem. 275: 5867–5873

  • Kwaan HC, Wang J, Svoboda K, Declerck PJ . 2000 Br. J Cancer 82: 1702–1708

  • Lawrence DA . 1997 Adv. Exp. Med. Biol. 425: 99–108

  • Lee DH, Goldberg AL . 1998 Trends Cell Biol. 8: 397–403

  • Li JJ, Colburn NH, Oberley LW . 1998 Carcinogenesis 19: 833–839

  • Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schulze-Osthoff K . 1995 Nature 375: 81–83

  • McGowen R, Biliran Jr H, Sager R, Sheng S . 2000 Cancer Res. 60: 4771–4778

  • Miura M, Friedlander RM, Yuan J . 1995 Proc. Natl. Acad. Sci. USA 92: 8318–8322

  • Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J . 1993 Cell 75: 653–660

  • Ossowski L, Aguirre-Ghiso JA . 2000 Curr. Opin. Cell. Biol. 12: 613–620

  • Palombella VJ, Rando OJ, Goldberg AL, Maniatis T . 1994 Cell 78: 773–785

  • Pemberton PA, Tipton AR, Pavloff N, Smith J, Erickson JR, Mouchabeck ZM, Kiefer MC . 1997 J. Histochem. Cytochem. 45: 1697–1706

  • Potempa J, Korzus E, Travis J . 1994 J. Biol. Chem. 269: 15957–15960

  • Sager R, Sheng S, Pemberton P, Hendrix MJ . 1996 Curr. Top. Microbiol. Immunol. 213: 51–64

  • Schleef RR, Chuang TL . 2000 J. Biol. Chem. 275: 26385–26389

  • Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJ . 1998 Cancer Res. 58: 5681–5685

  • Shao ZM, Nguyen M, Alpaugh ML, O'Connell JT, Barsky SH . 1998 Exp. Cell Res. 241: 394–403

  • Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R . 1996 Proc. Natl. Acad. Sci. USA 93: 11669–11674

  • Sheng S, Pemberton PA, Sager R . 1994 J. Biol. Chem. 269: 30988–30993

  • Sheng S, Truong B, Frederickson D, Wu R, Pardee AB, Sager R . 1998 Proc. Natl. Acad. Sci. USA 95: 499–504

  • Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F . 1986 Biochem. Biophys. Res. Commun. 135: 397–402

  • Tang D, Lahti JM, Kidd VJ . 2000 J. Biol. Chem. 275: 9303–9307

  • Travis J, Guzdek A, Potempa J, Watorek W . 1990 Biol. Chem. Hoppe Seyler 371: Suppl) 3–11

  • Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W, Grooten J, Fiers W, Vandenabeele P . 1998 J. Exp. Med. 187: 1477–1485

  • Yu FX, Lin SC, Morrison-Bogorad M, Atkinson MA, Yin HL . 1993 J. Biol. Chem. 268: 502–509

  • Zhang M, Sheng S, Maass N, Sager R . 1997 Mol. Med. 3: 49–59

  • Zhang M, Shi Y, Magit D, Furth PA, Sager R . 2000 Oncogene 19: 6053–6058

  • Zhang M, Magit D, Botteri F, Shi HY, He K, Li M, Furth P, Sager R . 1999 Dev. Biol. 215: 278–287

  • Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R . 1994 Science 263: 526–529

Download references

Acknowledgements

This work was supported in part by a Ruth Sager Memorial Fund (to S Sheng) and a DOD grant BC0996974 (to S Sheng). The authors wish to thank Mr Hector Biliran Jr and Dr Shuping Yin for critical review and proofreading of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shijie Sheng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, N., Meng, Y., Zhang, S. et al. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21, 4089–4098 (2002). https://doi.org/10.1038/sj.onc.1205507

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205507

Keywords

This article is cited by

Search

Quick links